Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.8.0.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 11,688 $ 14,006
Receivables 91 3,587
Prepaid expenses and other current assets 277 237
Total current assets 12,056 17,830
Property and equipment, net 684 837
Total assets 12,740 18,667
Current liabilities:    
Accounts payable 712 3,015
Accrued clinical trials expenses 706 1,387
Other accrued liabilities 554 455
Total current liabilities 1,972 4,857
Long-term debt 6,725 0
Warrant liabilities 5 619
Total liabilities 8,702 5,476
Commitments and contingencies
Stockholders’ equity:    
Common stock, at amounts paid-in 297,855 297,855
Additional paid-in capital 25,794 24,300
Accumulated deficit (319,611) (308,964)
Total stockholders’ equity 4,038 13,191
Total liabilities and stockholders’ equity $ 12,740 $ 18,667